The CMCO strives to promote a culture of diversity and inclusivity for all its members, focusing on career development and innovative approaches to science.
Center of Molecular and Cellular Oncology
The Center of Molecular and Cellular Oncology (CMCO) fosters and mentors physician-scientists as they advance their laboratory-based research programs to bridge fundamental cancer biology with clinical investigation for the translation of basic discoveries into better therapeutics, treatments or diagnosis. Physician-scientist faculty in the CMCO hold primary appointments in medical oncology or hematology at Yale Cancer Center (YCC), and participate in all divisional activities, interacting with other members of YCC. In addition, the CMCO members are part of one or more YCC disease-aligned research teams (DARTs) and YCC Research Programs relevant to their laboratory research and clinical interests, promoting a collaborative environment for the better understanding of cancer biology. The CMCO strives to promote a culture of diversity and inclusivity for all its members, focusing on career development and innovative approaches to science.
Contact Us
Markus Müschen, MD-PhD
Arthur H. and Isabel Bunker Professor of Hematology
Director, Center of Molecular and Cellular Oncology
Office Phone: 203-737-2792
Aline Matsuo, PhD
Program Manager
Office Phone: 203-737-1268
Center of Molecular and Cellular Oncology
Yale Cancer Center
300 George Street, Suite 6400
New Haven, CT 06511
Yale Cancer Center Grand Rounds | January 5, 2021Markus Muschen, MD, PhD
Yale Cancer Center Grand Rounds | November 10, 2020Robbert Bona, MD and Jeffrey Ishizuka, MD, DPhil
Faculty
Arthur H. and Isabel Bunker Professor of Medicine (Hematology) and Professor of Immunobiology; Director, Center of Molecular and Cellular Oncology
EducationMD, Heinrich-Heine-Universität Düsseldorf, 1999; PhD, Institute for Genetics Cologne, 2003Assistant Professor
EducationDPhil, Oxford University, 2008; MD, Harvard Medical School, 2013; BA, Williams CollegeAssistant Professor
EducationMD, Harvard Medical School, 2007; PhD, Yale University, 2002Assistant Professor of Medicine (Medical Oncology)
EducationAB, Princeton University, 2006; MD, Icahn School of Medicine at Mount Sinai, 2013; PhD, Courant Institute of Mathematical Sciences at New York University, 2012
Latest News
- April 24, 2022Source: Uro Today
EIKCS 2022: Biomarker Discovery Through Single-cell RNA Sequencing
- October 06, 2021
Yale’s Markus Müschen Receives Prestigious NCI Outstanding Investigator Award
- April 19, 2021
Yale Cancer Center Researchers Discover Common Mechanism Causing Autoimmune Disease and Blood Cancers
- February 01, 2021
Yale Cancer Center Researchers Discover Mechanism to Overcome Drug Resistance in B-Cell Acute Lymphoblastic Leukemia
- November 04, 2020
Yale Cancer Center Researchers Uncover New Mechanism of Immune-Cell Activation